PROTEOME SCIENCES PLC Logo

PROTEOME SCIENCES PLC

A Contract Research Organization focused on applied proteomics and peptidomics services.

PRM | IL

Overview

Corporate Details

ISIN(s):
GB0003104196
LEI:
213800Q62ICXANKU2986
Country:
United Kingdom
Address:
COVEHAM HOUSE, KT11 3EP COBHAM

Description

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-08 08:20
Substantial contract for Proteome Sciences
English 12.4 KB
2025-11-25 08:25
Appointment of Nominated Adviser and Broker
English 13.2 KB
2025-05-16 14:17
Result of AGM
English 10.7 KB
2025-02-21 08:00
Contract Win
English 12.5 KB
2024-12-23 08:08
Loan Facility, Trading Update & Directorate Change
English 17.8 KB
2024-09-13 08:00
Interim Results and Directorate Change
English 183.4 KB
2024-05-16 14:10
Result of AGM
English 10.5 KB
2024-05-16 08:00
AGM Statement
English 11.9 KB
2024-04-26 08:00
Contract Win
English 12.3 KB
2024-04-10 08:00
Final Results
English 231.2 KB
2024-01-02 08:00
Completion of new facility in San Diego
English 12.3 KB
2023-11-30 08:00
Trading Update
English 12.8 KB
2023-10-02 08:00
Launch of Single Cell Proteomics Services
English 12.7 KB
2023-08-30 15:14
Investor Presentation
English 11.5 KB
2023-08-25 08:00
Interim Results
English 186.0 KB

Automate Your Workflow. Get a real-time feed of all PROTEOME SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTEOME SCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTEOME SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.